Refine
Year of publication
- 2020 (92) (remove)
Document Type
- Article (92)
Language
- English (92) (remove)
Has Fulltext
- yes (92)
Is part of the Bibliography
- no (92)
Keywords
- - (86)
- plasma medicine (9)
- kINPen (7)
- reactive oxygen species (6)
- ROS (5)
- reactive oxygen and nitrogen species (5)
- <i>Streptococcus pneumoniae</i> (3)
- anticancer drugs (3)
- cold atmospheric plasma (3)
- proteomics (3)
- <i>Staphylococcus aureus</i> (2)
- ESBL (2)
- LL-37 (2)
- MRSA (2)
- Staphylococcus aureus (2)
- adaptation (2)
- antimicrobial resistance (2)
- basal ganglia (2)
- biofilm (2)
- cerebellum (2)
- chemical senses (2)
- cold physical plasma (2)
- cytotoxicity (2)
- drainage (2)
- epidemiology (2)
- hepatocellular carcinoma (2)
- host adaptation (2)
- mouse models (2)
- network (2)
- non-motor manifestation (2)
- oncology (2)
- paludiculture (2)
- percolation fen (2)
- resistance (2)
- rewetting (2)
- sensorimotor cortex (2)
- social interactions (2)
- taste (2)
- transcriptome (2)
- vaccine (2)
- virulence (2)
- 16S rRNA gene-sequencing (1)
- 3D model (1)
- 3D visualization (1)
- 5637 (1)
- <i>A. thaliana</i> (1)
- <i>Arundo donax</i> (1)
- <i>Candida lusitaniae</i> (1)
- <i>Ixodes ricinus</i> (1)
- <i>Janus kinase 2</i> (<i>JAK2</i>) (1)
- <i>Lannea barteri</i> (1)
- <i>Phragmites australis</i> (1)
- <i>S. aureus</i> (1)
- <i>S. pneumoniae</i> (1)
- <i>SLC16A1</i> (1)
- <i>Solanum lycopersicum</i> L. (1)
- <i>Staphylococcus lugdunensis</i> (1)
- <i>Typha latifolia</i> (1)
- ADGRE1 (1)
- AML (1)
- Actinobacteria (1)
- Alzheimer’s clinical syndrome (1)
- ApoE-KnockOut (1)
- Asia (1)
- Berlin Brandenburg Airport (1)
- CYP1A1 (1)
- CYP1A2 (1)
- Cambodia (1)
- Caucasus (1)
- Central Asia (1)
- Covid-19 (1)
- Creighton’s principles (1)
- Drishti (1)
- EMR1 (1)
- Enterobacterales (1)
- Euregio (1)
- Ewing’s sarcoma (1)
- F4/80 (1)
- FASN (1)
- FLT3 (1)
- FLT3-ITD (1)
- FLT3-TKD (1)
- FMS-like tyrosine kinase 3 (1)
- Fiji (1)
- Firmicutes (1)
- GPx1 knockout (1)
- Germany (1)
- Ghana (1)
- Gram-positive infections (1)
- HL-60 (1)
- HNSCC (1)
- HPTLC (1)
- HepG2 (1)
- IR-induced variants (1)
- IgE (1)
- Ilastik (1)
- JSNZ (1)
- KYSE 70 (1)
- LA-, HA-MRSA (1)
- LC-MS/MS (1)
- LIPSS (1)
- LNCaP (1)
- LPXTG (1)
- MDRO (1)
- MNT-1 (1)
- MSSA (1)
- Macrococcus (1)
- Massive Analysis of cDNA Ends (MACE) (1)
- NAFLD (1)
- NGS (1)
- Niemann–Pick disease type C1 (1)
- Omnilog (1)
- PC3 (1)
- PCV13 (1)
- PEF (1)
- Proteobacteria (1)
- RNA-seq (1)
- RNS (1)
- Roux-en-Y gastric bypass (1)
- S1P (1)
- SEA (1)
- SK-MEL-28 (1)
- SNVs (1)
- STEC (1)
- Shiga toxin-producing <i>Escherichia coli</i> (1)
- SiSo (1)
- Soviet Socialist Republics (1)
- Staphylococcus (1)
- SuperPred (1)
- SwissTargetPrediction (1)
- T cell superallergen (1)
- T cells (1)
- TGR(mREN2)27 (1)
- THP-1 (1)
- TIM-3 (1)
- Ti6Al4V (1)
- West Nile virus (1)
- Western diet (1)
- X-ray analysis (1)
- X-ray structure (1)
- abductor mechanism deficiency (1)
- acid resistance (1)
- acupuncture (1)
- acute myeloid leukemia (1)
- adherent human carcinoma cell lines (1)
- adipose-derived stem cells (1)
- adults (1)
- agriculture (1)
- airport development (1)
- allergy (1)
- amides (1)
- antibiotic resistance (1)
- antibiotic use (1)
- anticancer drug (1)
- antimicrobial peptide (1)
- antimicrobial peptides (1)
- apoptosis (1)
- arable farming (1)
- arbovirus (1)
- atherosclerosis (1)
- auricular acupuncture (1)
- autoantibodies (1)
- autologous lipotransfer (1)
- behavior change (1)
- bio-orthogonal click chemistry (1)
- biocompatibility (1)
- bioeconomy (1)
- biofilm degradation (1)
- biogas (1)
- biomedical model swine (1)
- bleeding tendency (1)
- blood smear (1)
- bortezomib (1)
- bovine (1)
- bovine ruminal acidosis (1)
- brain (1)
- breakthrough (1)
- breast cancer (1)
- c-Myc (1)
- cancer therapy (1)
- candidemia (1)
- carbon loss (1)
- carbon storage (1)
- carotid endarterectomy (1)
- cell fractionation (1)
- cell migration (1)
- cellobiose (1)
- cesarean section (1)
- chemokines (1)
- chondrosarcoma (1)
- chronic thromboembolic pulmonary hypertension (1)
- chronic wound (1)
- clear cell foci (1)
- climate change (1)
- climate change mitigation (1)
- clinically important restrictions and symptoms (1)
- clonal complex (1)
- cluster formation (1)
- co-infection (1)
- coagulation (1)
- cold atmospheric pressure plasma (1)
- cold physical plasmas (1)
- collective action (1)
- colonization type (1)
- combination therapy (1)
- concentration coefficient (1)
- confocal laser scanning microscopy (1)
- congenital heart disease (1)
- contribution margin (1)
- control diet (1)
- costing (1)
- counterfactual scenarios (1)
- crenolanib (1)
- cystic fibrosis (1)
- cytochrome P450 (1)
- daidzein (1)
- decontamination (1)
- dementia (1)
- denial (1)
- dermatology (1)
- diabetic foot (1)
- dihydrochalcones (1)
- dinutuximab beta (1)
- dirty mouse (1)
- displacement peat (1)
- dithiolene ligand (1)
- diversification (1)
- droplet microfluidics (1)
- drug resistance (1)
- drug–drug interaction (1)
- effective public participation (1)
- eicosanoids (1)
- emotions (1)
- enable-cluster (1)
- endothelial cells VEGF (1)
- endothelin receptor expression (1)
- endothelin system (1)
- estrogen receptor (1)
- executive functions (1)
- expression (1)
- feedstock (1)
- fen (1)
- fen rewetting (1)
- fibroblasts (1)
- fluorescence imaging (1)
- food spoilage (1)
- fractal (1)
- fronto-temporal cortex (1)
- fusidic acid (1)
- gag reflex (1)
- gastrointestinal microbiome (1)
- genetic predisposition (1)
- genistein (1)
- genome (1)
- gilteritinib (1)
- glucose uptake (1)
- glutaredoxin (1)
- glutathione (1)
- glutathione peroxidase-1 (1)
- gluteus maximus flap transfer (1)
- greenhouse gas (1)
- growth inhibition (1)
- growth inhibitory effect (1)
- guidelines (1)
- hBD3 (1)
- habitat (1)
- health services research (1)
- health-related quality of life (1)
- heat stress (1)
- hemolysis (1)
- hereditary thrombocytopenias (1)
- high fat diet (1)
- high-risk neuroblastoma (1)
- household income (1)
- human breast milk (1)
- hyaluronic acid microgels (1)
- hyperspectral imaging (1)
- imidazo[2,1-<i>c</i>][1,2,4]triazol-3(5<i>H</i>)-imines (1)
- immune evasion cluster (1)
- immune response (1)
- immunity (1)
- immunoadsorption (1)
- immunofluorescence (1)
- immunomodulation (1)
- immunotherapy (1)
- in silico target prediction (1)
- in vitro cytotoxic activity (1)
- inactivation (1)
- individualised intervention (1)
- infection (1)
- infection prevention (1)
- influenza A virus (1)
- inherited platelet disorders (1)
- inhibition (1)
- integrated multi-omics (1)
- interdisciplinary (1)
- invasion (1)
- iron (1)
- iron-sulfur cluster (1)
- laboratory (1)
- laser surface texturing (1)
- leaf (1)
- lidocaine (1)
- linear gradient (1)
- lipid mediators (1)
- lipidation (1)
- lipofilling (1)
- lipogenesis (1)
- lipoproteins (1)
- liver (1)
- liver disease (1)
- liver fibrosis (1)
- liver inflammation (1)
- liver pathology (1)
- livestock (1)
- livestock keeping (1)
- low-carbon behavior (1)
- low-grade inflammation (1)
- macro-remains (1)
- macrophage (1)
- magnetic moment (1)
- malnutrition (1)
- market analysis (1)
- mass spectrometry (1)
- maternal health care (1)
- matter fluxes (1)
- membrane functionality (1)
- membrane integrity (1)
- meta-analysis (1)
- metabolic activity (1)
- metabolic network (1)
- metabolism (1)
- metabolomics (1)
- metaproteomics (1)
- metastasis (1)
- methane (1)
- methanogens (1)
- methanotrophic bacteria (1)
- methicillin-resistant <i>Staphylococcus aureus</i> (1)
- miRNA (1)
- micro-remains (1)
- microRNA (1)
- microarray (1)
- microbiota (1)
- midostaurin (1)
- mixed-valence complex (1)
- molecular imaging (1)
- monocarboxylate transporter 1 (1)
- moral disengagement (1)
- mortality (1)
- multidrug-resistant microorganisms (1)
- natural products (1)
- neuropathy (1)
- nitrosative stress (1)
- non-alcoholic fatty liver disease (1)
- non-pollen palynomorphs (1)
- nucleus accumbens (1)
- nursing home (1)
- observational (1)
- observational study (1)
- oligotroph (1)
- oral nutritional supplement (1)
- organic matter loss (1)
- osteosarcoma (1)
- oxidative post-translational modifications (1)
- oxylipins (1)
- pancreatic cancer (1)
- peat (1)
- peat degradation (1)
- peatland management (1)
- peptidome (1)
- personal data (1)
- pig (1)
- pneumococcal carriage (1)
- pneumococcal colonization (1)
- pneumonia (1)
- polypharmacology (1)
- portal hypertension (1)
- pre-neoplastic lesions (1)
- predictor (1)
- preoperative anxiety (1)
- pretreatment (1)
- prostate cancer (1)
- protection (1)
- proteome (1)
- protocol (1)
- pulmonary arterial hypertension (1)
- pulmonary hypertension (1)
- pulmonary vascular resistance (1)
- qRT-PCR (1)
- quizartinib (1)
- radiation doses (1)
- randomized controlled trials (1)
- rare disease (1)
- rat (1)
- reactive nitrogen species (1)
- record linkage (1)
- redox signaling (1)
- reed beds (1)
- regulation (1)
- regulatory networks (1)
- relative entropy (1)
- repair mechanism (1)
- reservoir (1)
- respiratory tract infection (1)
- responsibility (1)
- root system (1)
- rural regions (1)
- sarcoma (1)
- screening (1)
- sea urchins (1)
- sedge peat (1)
- seedling (1)
- self-efficacy (1)
- semiautomated image analysis (1)
- sensitization (1)
- sepsis (1)
- serotypes (1)
- sigma factor σW (1)
- single nucleotide polymorphism (SNP) (1)
- site selection (1)
- skin cancer (1)
- smallholder (1)
- snoRNAs (1)
- socio-economic analyses (1)
- sodium bituminosulfonate (1)
- soil microbiome (1)
- sortase A (1)
- soy isoflavones (1)
- sphingolipids (1)
- sphingosine-1-phosphate receptors (1)
- standard (1)
- staphylococci (1)
- stem bark (1)
- storage conditions (1)
- stress signal (1)
- structure activity (1)
- sub-inhibitory concentrations (1)
- substituent (1)
- sulfate reducers (1)
- sulfonamides (1)
- superantigens (1)
- surface proteins (1)
- survival (1)
- susceptibility testing (1)
- sustainable agriculture <i>Typha angustifolia</i> (1)
- systematic review (1)
- targeted therapy (1)
- temperature (1)
- tetra-nuclear nickel complex (1)
- texture-modified diet (1)
- thatching companies (1)
- therapeutics (1)
- thermotolerance (1)
- thickness loss (1)
- thioglucoside conjugates (1)
- thioureas (1)
- tissue specificity (1)
- topological associating domains (1)
- total hip arthroplasty (1)
- transcriptome profile (1)
- transesophageal echocardiography (1)
- transition transversion ratio (1)
- translocation (1)
- transplantation (1)
- transporters (1)
- transstadial persistence (1)
- treatment control (1)
- trifunctionality (1)
- tumor spheroids (1)
- ureas (1)
- utilization (1)
- value chain (1)
- virtual screening (1)
- virulence genes (1)
- voxel-based morphometry (1)
- wetlands (1)
- white matter (1)
- wildling (1)
- wound healing (1)
- α1-Adrenergic receptor (1)
Institute
- Institut für Botanik und Landschaftsökologie & Botanischer Garten (9)
- Kliniken und Polikliniken für Innere Medizin (7)
- Abteilung für Mikrobiologie und Molekularbiologie (6)
- Friedrich-Loeffler-Institut für Medizinische Mikrobiologie (6)
- Interfakultäres Institut für Genetik und Funktionelle Genomforschung (MNF) (6)
- Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie/Plastische Operationen (6)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Immunologie (5)
- Institut für Pharmazie (5)
- Institut für Biochemie (3)
- Institut für Mathematik und Informatik (3)
Publisher
- MDPI (92) (remove)
Chondrosarcoma is the second most common malign bone tumor in adults. Surgical
resection of the tumor is recommended because of its resistance to clinical treatment such as
chemotherapy and radiation therapy. Thus, the prognosis for patients mainly depends on sufficient
surgical resection. Due to this, research on alternative therapies is needed. Cold atmospheric plasma
(CAP) is an ionized gas that contains various reactive species. Previous studies have shown an
anti-oncogenic potential of CAP on different cancer cell types. The current study examined the effects
of treatment with CAP on two chondrosarcoma cell lines (CAL-78, SW1353). Through proliferation
assay, the cell growth after CAP-treatment was determined. A strong antiproliferative effect for
both cell lines was detected. By fluorescein diacetate (FDA) assay and ATP release assay, alterations
in the cell membrane and associated translocation of low molecular weight particles through the
cytoplasmic membrane were observed. In supernatant, the non-membrane-permeable FDA and
endogenously synthesized ATP detected suggest an increased membrane permeability after CAP
treatment. Similar results were shown by the dextran-uptake assay. Furthermore, fluorescence
microscopic G-/F-actin assay was performed. G- and F-actin were selectively dyed, and the ratio
was measured. The presented results indicate CAP-induced changes in cell membrane function and
possible alterations in actin-cytoskeleton, which may contribute to the antiproliferative effects of CAP.
Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity.
Especially, the development of fibrosis and portal hypertension in NAFLD patients requires treatment.
Transgenic TGR(mREN2)27 rats overexpressing mouse renin spontaneously develop NAFLD with
portal hypertension but without obesity. This study investigated the additional role of obesity in this
model on the development of portal hypertension and fibrosis. Obesity was induced in twelve-week
old TGR(mREN2)27 rats after receiving Western diet (WD) for two or four weeks. Liver fibrosis
was assessed using standard techniques. Hepatic expression of transforming growth factor-β1
(TGF-β1), collagen type Iα1, α-smooth muscle actin, and the macrophage markers Emr1, as well as
the chemoattractant Ccl2, interleukin-1β (IL1β) and tumor necrosis factor-α (TNFα) were analyzed.
Assessment of portal and systemic hemodynamics was performed using the colored microsphere
technique. As expected, WD induced obesity and liver fibrosis as confirmed by Sirius Red and Oil Red
O staining. The expression of the monocyte-macrophage markers, Emr1, Ccl2, IL1β and TNFα were
increased during feeding of WD, indicating infiltration of macrophages into the liver, even though this
increase was statistically not significant for the EGF module-containing mucin-like receptor (Emr1)
mRNA expression levels. Of note, portal pressure increased with the duration of WD compared
to animals that received a normal chow. Besides obesity, WD feeding increased systemic vascular
resistance reflecting systemic endothelial and splanchnic vascular dysfunction. We conclude that
transgenic TGR(mREN2)27 rats are a suitable model to investigate NAFLD development with liver
fibrosis and portal hypertension. Tendency towards elevated expression of Emr1 is associated with
macrophage activity point to a significant role of macrophages in NAFLD pathogenesis, probably
due to a shift of the renin–angiotensin system towards a higher activation of the classical pathway.The hepatic injury induced by WD in TGR(mREN2)27 rats is suitable to evaluate different stages of
fibrosis and portal hypertension in NAFLD with obesity
Previous studies have reported the fundamental role of immunoregulatory
proteins in the clinical phenotype and outcome of sepsis. This study investigated two functional single
nucleotide polymorphisms (SNPs) of T cell immunoglobulin and mucin domain-containing protein 3
(TIM-3), which has a negative stimulatory function in the T cell immune response. Methods: Patients
with sepsis (n = 712) were prospectively enrolled from three intensive care units (ICUs) at the University
Medical Center Goettingen since 2012. All patients were genotyped for the TIM-3 SNPs rs1036199 and
rs10515746. The primary outcome was 28-day mortality. Disease severity and microbiological findings
were secondary endpoints. Results: Kaplan–Meier survival analysis demonstrated a significantly
lower 28-day mortality for TIM-3 rs1036199 AA homozygous patients compared to C-allele carriers
(18% vs. 27%, p = 0.0099) and TIM-3 rs10515746 CC homozygous patients compared to A-allele
carriers (18% vs. 26%, p = 0.0202). The TIM-3 rs1036199 AA genotype and rs10515746 CC genotype
remained significant predictors for 28-day mortality in the multivariate Cox regression analysis after
adjustment for relevant confounders (adjusted hazard ratios: 0.67 and 0.70). Additionally, patients
carrying the rs1036199 AA genotype presented more Gram-positive and Staphylococcus epidermidis
infections, and rs10515746 CC homozygotes presented more Staphylococcus epidermidis infections.
Conclusion: The studied TIM-3 genetic variants are associated with altered 28-day mortality and
susceptibility to Gram-positive infections in sepsis.
The local anesthetic lidocaine, which has been used extensively during liposuction, has been
reported to have cytotoxic effects and therefore would be unsuitable for use in autologous lipotransfer.
We evaluated the effect of lidocaine on the distribution, number, and viability of adipose-derived stem
cells (ASCs), preadipocytes, mature adipocytes, and leukocytes in the fatty and fluid portion of the
lipoaspirate using antibody staining and flow cytometry analyses. Adipose tissue was harvested from
11 female patients who underwent liposuction. Abdominal subcutaneous fat tissue was infiltrated
with tumescent local anesthesia, containing lidocaine on the left and lacking lidocaine on the right
side of the abdomen, and harvested subsequently. Lidocaine had no influence on the relative
distribution, cell number, or viability of ASCs, preadipocytes, mature adipocytes, or leukocytes in the
stromal-vascular fraction. Assessing the fatty and fluid portions of the lipoaspirate, the fatty portions
contained significantly more ASCs (p < 0.05), stem cells expressing the preadipocyte marker Pref-1
(p < 0.01 w/lidocaine, p < 0.05 w/o lidocaine), and mature adipocytes (p < 0.05 w/lidocaine, p < 0.01
w/o lidocaine) than the fluid portions. Only the fatty portion should be used for transplantation. This
study found no evidence that would contraindicate the use of lidocaine in lipotransfer. Limitations of
the study include the small sample size and the inclusion of only female patients.
Natural products comprise a rich reservoir for innovative drug leads and are a constant
source of bioactive compounds. To find pharmacological targets for new or already known
natural products using modern computer-aided methods is a current endeavor in drug discovery.
Nature’s treasures, however, could be used more effectively. Yet, reliable pipelines for the
large-scale target prediction of natural products are still rare. We developed an in silico workflow
Int. J. Mol. Sci. 2020, 21, 7102; doi:10.3390/ijms21197102 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2020, 21, 7102 2 of 18
consisting of four independent, stand-alone target prediction tools and evaluated its performance
on dihydrochalcones (DHCs)—a well-known class of natural products. Thereby, we revealed
four previously unreported protein targets for DHCs, namely 5-lipoxygenase, cyclooxygenase-1,
17β-hydroxysteroid dehydrogenase 3, and aldo-keto reductase 1C3. Moreover, we provide a
thorough strategy on how to perform computational target predictions and guidance on using the
respective tools.
Membrane monocarboxylate transporter 1 (SLC16A1/MCT1) plays an important role in
hepatocyte homeostasis, as well as drug handling. However, there is no available information
about the impact of liver pathology on the transporter levels and function. The study was aimed to
quantify SLC16A1 mRNA (qRT-PCR) and MCT1 protein abundance (liquid chromatography–tandem
mass spectrometry (LC¬¬–MS/MS)) in the livers of patients diagnosed, according to the standard
clinical criteria, with hepatitis C, primary biliary cirrhosis, primary sclerosing hepatitis, alcoholic liver
disease (ALD), and autoimmune hepatitis. The stage of liver dysfunction was classified according to
Child–Pugh score. Downregulation of SLC16A1/MCT1 levels was observed in all liver pathology
states, significantly for ALD. The progression of liver dysfunction, from Child–Pugh class A to C,
involved the gradual decline in SLC16A1 mRNA and MCT1 protein abundance, reaching a clinically
significant decrease in class C livers. Reduced levels of MCT1 were associated with significant
intracellular lactate accumulation. The MCT1 transcript and protein did not demonstrate significant
correlations regardless of the liver pathology analyzed, as well as the disease stage, suggesting
posttranscriptional regulation, and several microRNAs were found as potential regulators of MCT1
abundance. MCT1 membrane immunolocalization without cytoplasmic retention was observed in all
studied liver pathologies. Overall, the study demonstrates that SLC16A1/MCT1 is involved in liver
pathology, especially in ALD
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often
caused by recurrent emboli. These are also frequently found in patients with myeloproliferative
diseases. While myeloproliferative diseases can be caused by gene defects, the genetic predisposition
to CTEPH is largely unexplored. Therefore, the objective of this study was to analyse these genes
and further genes involved in pulmonary hypertension in CTEPH patients. A systematic screening
was conducted for pathogenic variants using a gene panel based on next generation sequencing.
CTEPH was diagnosed according to current guidelines. In this study, out of 40 CTEPH patients
4 (10%) carried pathogenic variants. One patient had a nonsense variant (c.2071A>T p.Lys691*)
in the BMPR2 gene and three further patients carried the same pathogenic variant (missense variant,
c.1849G>T p.Val617Phe) in the Janus kinase 2 (JAK2) gene. The latter led to a myeloproliferative
disease in each patient. The prevalence of this JAK2 variant was significantly higher than expected
(p < 0.0001). CTEPH patients may have a genetic predisposition more often than previously thought.
The predisposition for myeloproliferative diseases could be an additional risk factor for CTEPH
development. Thus, clinical screening for myeloproliferative diseases and genetic testing may be
considered also for CTEPH patients.
Liver diseases are important causes of morbidity and mortality worldwide. The aim of
this study was to identify differentially expressed microRNAs (miRNAs), target genes, and key
pathways as innovative diagnostic biomarkers in liver patients with different pathology and functional
state. We determined, using RT-qPCR, the expression of 472 miRNAs in 125 explanted livers from
subjects with six different liver pathologies and from control livers. ANOVA was employed to
obtain differentially expressed miRNAs (DEMs), and miRDB (MicroRNA target prediction database)
was used to predict target genes. A miRNA–gene differential regulatory (MGDR) network was
constructed for each condition. Key miRNAs were detected using topological analysis. Enrichment
analysis for DEMs was performed using the Database for Annotation, Visualization, and Integrated
Discovery (DAVID). We identified important DEMs common and specific to the different patient
groups and disease progression stages. hsa-miR-1275 was universally downregulated regardless
the disease etiology and stage, while hsa-let-7a*, hsa-miR-195, hsa-miR-374, and hsa-miR-378 were
deregulated. The most significantly enriched pathways of target genes controlled by these miRNAs
comprise p53 tumor suppressor protein (TP53)-regulated metabolic genes, and those involved in
regulation of methyl-CpG-binding protein 2 (MECP2) expression, phosphatase and tensin homolog
(PTEN) messenger RNA (mRNA) translation and copper homeostasis. Our findings show a novel
panel of deregulated miRNAs in the liver tissue from patients with different liver pathologies. These
miRNAs hold potential as biomarkers for diagnosis and staging of liver diseases.
Hepatocellular carcinoma (HCC) is a deadly form of liver malignancy with limited treatment
options. Amplification and/or overexpression of c-MYC is one of the most frequent genetic events
in human HCC. The mammalian target of Rapamycin Complex 1 (mTORC1) is a major functional
axis regulating various aspects of cellular growth and metabolism. Recently, we demonstrated that
mTORC1 is necessary for c-Myc driven hepatocarcinogenesis as well as for HCC cell growth in vitro.
Among the pivotal downstream effectors of mTORC1, upregulation of Fatty Acid Synthase (FASN) and
its mediated de novo lipogenesis is a hallmark of human HCC. Here, we investigated the importance
of FASN on c-Myc-dependent hepatocarcinogenesis using in vitro and in vivo approaches. In mouse
and human HCC cells, we found that FASN suppression by either gene silencing or soluble inhibitors
more effectively suppressed proliferation and induced apoptosis in the presence of high c-MYC
expression. In c-Myc/Myeloid cell leukemia 1 (MCL1) mouse liver tumor lesions, FASN expression
was markedly upregulated. Most importantly, genetic ablation of Fasn profoundly delayed (without
abolishing) c-Myc/MCL1 induced HCC formation. Liver tumors developing in c-Myc/MCL1 mice
depleted of Fasn showed a reduction in proliferation and an increase in apoptosis when compared
with corresponding lesions from c-Myc/MCL1 mice with an intact Fasn gene. In human HCC samples,
a significant correlation between the levels of c-MYC transcriptional activity and the expression
of FASN mRNA was detected. Altogether, our study indicates that FASN is an important effector
downstream of mTORC1 in c-MYC induced HCC. Targeting FASN may be helpful for the treatment
of human HCC, at least in the tumor subset displaying c-MYC amplification or activation.
Despite continuous advances in therapy, malignant melanoma is still among the deadliest
types of cancer. At the same time, owing to its high plasticity and immunogenicity, melanoma is
regarded as a model tumor entity when testing new treatment approaches. Cold physical plasma is a
novel anticancer tool that utilizes a plethora of reactive oxygen species (ROS) being deposited on the
target cells and tissues. To test whether plasma treatment would enhance the toxicity of an established
antitumor therapy, ionizing radiation, we combined both physical treatment modalities targeting
B16F10 murine melanoma cell in vitro. Repeated rather than single radiotherapy, in combination
with gas plasma-introduced ROS, induced apoptosis and cell cycle arrest in an additive fashion. In
tendency, gas plasma treatment sensitized the cells to subsequent radiotherapy rather than the other
way around. This was concomitant with increased levels of TNFα, IL6, and GM-CSF in supernatants.
Murine JAWS dendritic cells cultured in these supernatants showed an increased expression of cell
surface activation markers, such as MHCII and CD83. For PD-L1 and PD-L2, increased expression
was observed. Our results are the first to suggest an additive therapeutic effect of gas plasma and
radiotherapy, and translational tumor models are needed to develop this concept further.